NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Diabetes Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Diabetes Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Diabetes Pathogenesis



Glucagon works to induce ERK 1/2 phosphorylation and raise mesangial cell proliferation



April 10th, 2006

Glucagon activates specific receptors to induce ERK 1/2 phosphorylation and thereby increase mesangial cell proliferation.

According to recent research from the United States, "Glucagon, a major insulin counter-regulatory hormone, binds to specific Gs protein-coupled receptors to activate glycogenolytic and gluconeogenic pathways, causing blood glucose levels to increase. Inappropriate increases in serum glucagon play a critical role in the development of insulin resistance and target organ damage in type 2 diabetes."

X.C. Li and colleagues at Henry Ford Hospital hypotheses: "(1) glucagon induces proliferation of rat glomerular mesangial...


Source: Diabetes Week (2006-04-10)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login